• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (208)   Subscriber (50364)
For: Gysin B, Trivedi D, Johnson DG, Hruby VJ. Design and synthesis of glucagon partial agonists and antagonists. Biochemistry 1986;25:8278-84. [PMID: 3814583 DOI: 10.1021/bi00373a023] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Number Cited by Other Article(s)
1
Scheen AJ, Paquot N, Lefèbvre PJ. Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert Opin Investig Drugs 2017;26:1373-1389. [PMID: 29052441 DOI: 10.1080/13543784.2017.1395020] [Citation(s) in RCA: 58] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
2
Filipski KJ. Small molecule glucagon receptor antagonists: a patent review (2011 – 2014). Expert Opin Ther Pat 2015;25:819-30. [DOI: 10.1517/13543776.2015.1032250] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
3
Cho YM, Merchant CE, Kieffer TJ. Targeting the glucagon receptor family for diabetes and obesity therapy. Pharmacol Ther 2012;135:247-78. [DOI: 10.1016/j.pharmthera.2012.05.009] [Citation(s) in RCA: 93] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2012] [Accepted: 05/15/2012] [Indexed: 12/11/2022]
4
Burcelin R, Knauf C, Cani P. Pancreatic α-cell dysfunction in diabetes. DIABETES & METABOLISM 2008;34 Suppl 2:S49-55. [DOI: 10.1016/s1262-3636(08)73395-0] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
5
Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007;28:84-116. [PMID: 17261637 DOI: 10.1210/er.2006-0007] [Citation(s) in RCA: 424] [Impact Index Per Article: 24.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
6
Pan CQ, Buxton JM, Yung SL, Tom I, Yang L, Chen H, MacDougall M, Bell A, Claus TH, Clairmont KB, Whelan JP. Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonist. J Biol Chem 2006;281:12506-15. [PMID: 16505481 DOI: 10.1074/jbc.m600127200] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]  Open
7
Sturm NS, Hutzler AM, David CS, Azizeh BY, Trivedi D, Hruby VJ. Structure-activity studies of hydrophobic amino acid replacements at positions 9, 11 and 16 of glucagon. THE JOURNAL OF PEPTIDE RESEARCH : OFFICIAL JOURNAL OF THE AMERICAN PEPTIDE SOCIETY 1997;49:293-9. [PMID: 9176812 DOI: 10.1111/j.1399-3011.1997.tb01129.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
8
Azizeh BY, Van Tine BA, Trivedi D, Hruby VJ. Pure glucagon antagonists: biological activities and cAMP accumulation using phosphodiesterase inhibitors. Peptides 1997;18:633-41. [PMID: 9213355 DOI: 10.1016/s0196-9781(97)00131-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
9
Dharanipragada R, Trivedi D, Bannister A, Siegel M, Tourwe D, Mollova N, Schram K, Hruby VJ. Synthetic linear and cyclic glucagon antagonists. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 1993;42:68-77. [PMID: 8396562 DOI: 10.1111/j.1399-3011.1993.tb00352.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
10
Mollova NN, Schram KH, Lin Y, Dharanipragada R, Hruby VJ. Characterization of linear and cyclic glucagon analogs by fast atom bombardment mass spectrometry. BIOLOGICAL MASS SPECTROMETRY 1993;22:267-76. [PMID: 8507672 DOI: 10.1002/bms.1200220502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/09/2023]
11
Hruby VJ. Chapter 18 Strategies in the development of peptide antagonists. PROGRESS IN BRAIN RESEARCH 1992;92:215-24. [PMID: 1363847 DOI: 10.1016/s0079-6123(08)61177-2] [Citation(s) in RCA: 29] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
12
Zechel C, Trivedi D, Hruby VJ. Synthetic glucagon antagonists and partial agonists. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 1991;38:131-8. [PMID: 1664420 DOI: 10.1111/j.1399-3011.1991.tb01420.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
13
Bharucha DB, Tager HS. Analysis of glucagon-receptor interactions on isolated canine hepatocytes. Formation of reversibly and irreversibly cell-associated hormone. J Biol Chem 1990. [DOI: 10.1016/s0021-9258(19)39735-2] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
14
Glucagon Antagonists: Contribution to Binding and Activity of the Amino-terminal Sequence 1–5, Position 12, and the Putative α-Helical Segment 19–27. J Biol Chem 1989. [DOI: 10.1016/s0021-9258(19)85011-1] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
15
Krstenansky JL, Zechel C, Trivedi D, Hruby VJ. Importance of the C-terminal alpha-helical structure for glucagon's biological activity. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 1988;32:468-75. [PMID: 2854536 DOI: 10.1111/j.1399-3011.1988.tb01377.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
16
Robberect P, Damien C, Moroder L, Coy DH, Wünsch E, Christophe J. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29. REGULATORY PEPTIDES 1988;21:117-28. [PMID: 2839870 DOI: 10.1016/0167-0115(88)90096-1] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
17
Hagopian WA, Tager HS, Gysin B, Trivedi D, Hruby VJ. Interactions of glucagon and glucagon analogs with isolated canine hepatocytes. J Biol Chem 1987. [DOI: 10.1016/s0021-9258(18)47755-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]  Open
18
Stimulation and inhibition of cAMP accumulation by glucagon in canine hepatocytes. J Biol Chem 1987. [DOI: 10.1016/s0021-9258(18)47756-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA